Primary study · included by 1 review
Clinical Characteristics and Treatment Outcome of Langerhans Cell Histiocytosis: 22 Years’ Experience of 154 Patients at a Single Center
Lee 2014 · Lee Ji Won, Shin Hee Young, Kang Hyoung Jin, et al. · Pediatric Hematology and Oncology · 2014
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.097 [0.076, 0.119] | 11 studies · 1806 participants | GRADE not reported |
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.205 [0.144, 0.267] | 16 studies · 2052 participants | Low |
Prevalence of oral manifestations Oral manifestations (oral mucosa and jaw bone lesions) vs Not applicable · At diagnosis | Prevalence (%) 14.86 [11.80, 18.58] | 16 studies · 2052 participants | Low |
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified) | Proportion 0.1057 | 11 studies · 1806 participants | GRADE not reported |
1 including review in total.